IDV vehicle

36F79721D0246

65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Veterans Affairs
OfficeNAC FEDERAL SUPPLY SCHEDULE (36F797)
NAICS325412 — Pharmaceutical Preparation Manufacturing
PSC6505 — Drugs and Biologicals
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeFIXED PRICE WITH ECONOMIC PRICE ADJUSTMENT
Obligations$0
Current contract valueNot reported
Potential contract value / ceiling$2.3M
Start dateSep 15, 2021
Current end dateNot available
Potential end dateNot available
Latest award activityAug 13, 2026
Source loadedSep 19, 2026

Funding and modification history

Showing the latest 22 of 22 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Aug 13, 2026P00021$0TEMP EXT
Dec 1, 2025P00020$0PUBLIC LAW 2026
Oct 1, 2025P00019$0ADMINISTRATIVE CHANGE
Mar 5, 2025P00018$0ADMINISTRATIVE CHANGE: US MADE
Jan 13, 2025P00017$0ADMINISTRATIVE - CORRECTION
Jan 10, 2025P00016$0PRICE INCREASE
Nov 25, 2024P00015$0PUBLIC LAW 2025
Jan 18, 2024P00014$0NDC CHANGE
Dec 6, 2023P00013$0NDC CHANGE
Nov 14, 2023P00012$0PUBLIC LAW 102-585
Nov 2, 2023P00011$0NDC CHANGE
Oct 3, 2023P00010$042-2A: NDC CHANGE
Apr 18, 2023P00009$042-2A: OGA PRICE INCREASE
Apr 14, 2023P00007$042-2A: PRODUCT ADDITION
Apr 14, 2023P00008$0ADMINISTRATIVE CHANGE : CORRECTION TO PRODUCT ADDITION
Mar 20, 2023P00006$0NOVATION AGREEMENT
Jan 31, 2023P00005$042-2A: PRODUCT ADDITIONS
Nov 22, 2022P00004$0PUBLIC LAW 2023
Jun 13, 2022P00003$042-2A: PRICE INCREASE
Jun 3, 2022P00002$0UPDATE SIGNATORY AUTHORITY FORM
Dec 16, 2021P00001$0PUBLIC LAW 2022
Sep 1, 20210$065 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD

Research next steps

  1. Check the stated set-aside against the solicitation and current certifications.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.